[Current recommendations for the systemic treatment of metastatic renal cell carcinoma].

[Current recommendations for the systemic treatment of metastatic renal cell carcinoma].
Aktuelle Urol. 2019 Sep 04;:
Authors: Kröger N, Merseburger AS, Bedke J
Abstract
Numerous substances are available for the treatment of metastatic renal cell carcinoma (mRCC). Therefore, medical treatment of patients with mRCC has become a very complex subject. This review summarises clinical studies and typical side-effects of currently available agents that have been approved in Germany. The authors give suggestions for the use of these substances in the different therapy lines.
PMID: 31486060 [PubMed - as supplied by publisher]

Source: Aktuelle Urologie - September 3, 2019 Category: Urology & Nephrology Authors: Kröger N, Merseburger AS, Bedke J Tags: Aktuelle Urol Source Type: research